Skip to content

Kevin Ackerman

NPI 1255950150ActiveIndividual· Pediatrics, Pediatric Allergy/Immunology· Philadelphia, PA

Pediatrics, Pediatric Allergy/Immunology in Philadelphia, Pennsylvania, licensed in PA, with an NPI issued in April 2020. Part D covered 84 prescriptions written in 2024, 87% of them generic. Genentech USA, Inc. reported $133.41 in payments in 2025, mostly food and beverage.

Overview

NPI1255950150
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedApr 10, 2020
Last updated in NPPESMay 30, 2024
Certified by providerMay 30, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Pediatric Allergy/Immunology Primary2080P0201XMT221188PA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)84 · 175 30-day fills
Patients24
Total drug cost$14,323
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$133.41 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Genentech USA, Inc.$133.411

What the 2025 payments were for

  • Food and Beverage$133.41 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Allergy/Immunology providers in Philadelphia

All Pediatrics, Pediatric Allergy/Immunology providers in Pennsylvania →